Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for ARCT

Stock NameArcturus Therapeutics Holdings Inc
TickerARCT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS03969T1097

Show aggregate ARCT holdings

News associated with ARCT

Arcturus Therapeutics (NASDAQ:ARCT) Given New $54.00 Price Target at Leerink Partners
Arcturus Therapeutics (NASDAQ:ARCT – Free Report) had its price target cut by Leerink Partners from $63.00 to $54.00 in a report released on Friday,Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. ARCT has been the subject of a number of other reports. Canaccord Genuity Group decreased their target price on […] - 2025-08-25 02:12:53
Mitsubishi UFJ Asset Management Co. Ltd. Grows Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 9.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,693 shares of the biotechnology company’s stock after buying an additional 1,232 shares during […] - 2025-08-15 04:46:53
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Average Rating of “Buy” from Brokerages
Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) have received an average rating of “Buy” from the seven analysts that are currently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued ratings on the stock […] - 2025-08-12 04:42:57
Empire Life Investments Inc. Sells 14,554 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
Empire Life Investments Inc. trimmed its position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 5.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 264,909 shares of the biotechnology company’s stock after selling 14,554 shares during the period. […] - 2025-08-04 04:44:57
Alps Advisors Inc. Trims Stock Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
Alps Advisors Inc. reduced its holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 8.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,949 shares of the biotechnology company’s stock after selling 1,952 shares during the quarter. Alps Advisors Inc. owned approximately […] - 2025-07-18 04:49:09
Sumitomo Mitsui Trust Group Inc. Reduces Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
Sumitomo Mitsui Trust Group Inc. reduced its position in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 6.7% in the first quarter, HoldingsChannel.com reports. The firm owned 1,926,084 shares of the biotechnology company’s stock after selling 138,966 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.07% of Arcturus Therapeutics […] - 2025-07-04 05:12:59
Arcturus Therapeutics (NASDAQ:ARCT) Stock Crosses Below 200 Day Moving Average – Time to Sell?
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $14.13 and traded as low as $13.74. Arcturus Therapeutics shares last traded at $14.41, with a volume of 517,333 shares changing hands. Wall Street Analyst […] - 2025-06-27 05:22:55
Arcturus Therapeutics (NASDAQ:ARCT) Now Covered by Scotiabank
Scotiabank began coverage on shares of Arcturus Therapeutics (NASDAQ:ARCT – Get Free Report) in a report released on Wednesday, Marketbeat Ratings reports. The brokerage set a “sector outperform” rating and a $32.00 price target on the biotechnology company’s stock. Scotiabank’s price objective would suggest a potential upside of 151.37% from the company’s previous close. A […] - 2025-05-30 02:38:46
Cresset Asset Management LLC Sells 2,198 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
Cresset Asset Management LLC decreased its position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 16.0% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 11,511 shares of the biotechnology company’s stock after selling 2,198 shares during the period. Cresset Asset Management LLC’s holdings in […] - 2025-05-19 05:02:55
Arcturus Therapeutics (NASDAQ:ARCT) Given New $66.00 Price Target at Canaccord Genuity Group
Arcturus Therapeutics (NASDAQ:ARCT – Free Report) had its target price reduced by Canaccord Genuity Group from $68.00 to $66.00 in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. ARCT has been the topic of a number of other research reports. HC Wainwright […] - 2025-05-14 04:58:54
Hsbc Holdings PLC Increases Stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
Hsbc Holdings PLC grew its position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 11.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,368 shares of the biotechnology company’s stock after acquiring an additional 2,673 shares during the […] - 2025-05-08 06:07:00
Barclays PLC Lowers Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
Barclays PLC trimmed its position in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 10.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 60,082 shares of the biotechnology company’s stock after selling 7,333 shares during the period. Barclays PLC’s holdings in Arcturus Therapeutics were worth $1,020,000 as of its most […] - 2025-05-06 04:38:59
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Stock Holdings Lessened by Franklin Resources Inc.
Franklin Resources Inc. lessened its holdings in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 100,677 shares of the biotechnology company’s stock after selling 3,259 shares during the period. […] - 2025-04-15 05:32:54
Mitsubishi UFJ Asset Management Co. Ltd. Purchases 4,647 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 52.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,461 shares of the biotechnology company’s stock after acquiring an additional 4,647 […] - 2025-04-04 05:12:56
AlphaQuest LLC Sells 12,668 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
AlphaQuest LLC cut its stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 63.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,142 shares of the biotechnology company’s stock after selling 12,668 shares during the period. AlphaQuest LLC’s holdings in […] - 2025-03-19 06:06:45
Arcturus Therapeutics (NASDAQ:ARCT) Given New $68.00 Price Target at Canaccord Genuity Group
Arcturus Therapeutics (NASDAQ:ARCT – Get Free Report) had its price objective reduced by stock analysts at Canaccord Genuity Group from $74.00 to $68.00 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 414.76% […] - 2025-03-12 04:08:56
Arcturus Therapeutics (NASDAQ:ARCT) Share Price Passes Below 200-Day Moving Average – Here’s Why
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $18.81 and traded as low as $16.51. Arcturus Therapeutics shares last traded at $16.69, with a volume of 364,852 shares. Wall Street Analysts Forecast Growth Several research […] - 2025-02-25 06:50:59
Spire Wealth Management Increases Stock Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
Spire Wealth Management increased its holdings in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 393.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,478 shares of the biotechnology company’s stock after buying an additional 10,746 shares during the […] - 2025-02-07 07:05:06

iShares Healthcare Innovation UCITS ETF USD (Acc) ARCT holdings

DateNumber of ARCT Shares HeldBase Market Value of ARCT SharesLocal Market Value of ARCT SharesChange in ARCT Shares HeldChange in ARCT Base ValueCurrent Price per ARCT Share HeldPrevious Price per ARCT Share Held
2025-11-11 (Tuesday)26,701USD 231,498USD 231,498
2025-11-10 (Monday)26,701USD 234,435ARCT holding increased by 1602USD 234,4350USD 1,602 USD 8.78001 USD 8.72001
2025-11-07 (Friday)26,701USD 232,833ARCT holding increased by 11482USD 232,8330USD 11,482 USD 8.72001 USD 8.28999
2025-11-06 (Thursday)26,701USD 221,351ARCT holding decreased by -9346USD 221,3510USD -9,346 USD 8.28999 USD 8.64001
2025-11-05 (Wednesday)26,701USD 230,697ARCT holding decreased by -7743USD 230,6970USD -7,743 USD 8.64001 USD 8.93
2025-11-04 (Tuesday)26,701USD 238,440ARCT holding decreased by -9879USD 238,4400USD -9,879 USD 8.93 USD 9.29999
2025-11-03 (Monday)26,701USD 248,319ARCT holding decreased by -17890USD 248,3190USD -17,890 USD 9.29999 USD 9.97
2025-10-31 (Friday)26,701USD 266,209ARCT holding increased by 9078USD 266,2090USD 9,078 USD 9.97 USD 9.63001
2025-10-30 (Thursday)26,701USD 257,131ARCT holding increased by 5074USD 257,1310USD 5,074 USD 9.63001 USD 9.43998
2025-10-29 (Wednesday)26,701USD 252,057ARCT holding decreased by -11749USD 252,0570USD -11,749 USD 9.43998 USD 9.88
2025-10-28 (Tuesday)26,701USD 263,806ARCT holding decreased by -18958USD 263,8060USD -18,958 USD 9.88 USD 10.59
2025-10-27 (Monday)26,701USD 282,764ARCT holding decreased by -16821USD 282,7640USD -16,821 USD 10.59 USD 11.22
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ARCT by Blackrock for IE00BYZK4776

Show aggregate share trades of ARCT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-24SELL-23211.22012.070 11.985USD -2,781 15.16 Profit of 737 on sale
2025-09-11BUY11718.04018.690 18.625USD 2,179 14.60
2025-07-08SELL-11513.80014.520 14.448USD -1,662 14.59 Profit of 16 on sale
2025-06-24SELL-12113.41013.550 13.536USD -1,638 14.65 Profit of 135 on sale
2025-06-23SELL-12112.51012.520 12.519USD -1,515 14.67 Profit of 260 on sale
2025-06-11SELL-11812.44013.320 13.232USD -1,561 14.80 Profit of 185 on sale
2025-05-30SELL-11912.53012.830 12.800USD -1,523 14.95 Profit of 256 on sale
2025-05-21BUY11912.15012.410 12.384USD 1,474 15.11
2025-05-14SELL-70810.84011.860 11.758USD -8,325 15.23 Profit of 2,459 on sale
2025-04-30SELL-11612.81012.870 12.864USD -1,492 15.57 Profit of 314 on sale
2025-04-28SELL-11712.82013.200 13.162USD -1,540 15.63 Profit of 288 on sale
2025-04-25SELL-11612.91012.980 12.973USD -1,505 15.65 Profit of 311 on sale
2025-04-11SELL-7509.7009.880 9.862USD -7,397 16.05 Profit of 4,642 on sale
2025-04-08SELL-3668.9109.460 9.405USD -3,442 16.28 Profit of 2,517 on sale
2025-04-07SELL-2509.0909.130 9.126USD -2,282 16.37 Profit of 1,810 on sale
2025-03-31SELL-24010.59011.240 11.175USD -2,682 16.68 Profit of 1,322 on sale
2025-03-21SELL-23612.88012.930 12.925USD -3,050 17.02 Profit of 967 on sale
2025-03-12SELL-12214.26014.500 14.476USD -1,766 17.35 Profit of 351 on sale
2025-02-28SELL-12216.79016.900 16.889USD -2,060 17.63 Profit of 90 on sale
2025-02-25BUY12116.06016.940 16.852USD 2,039 17.70
2025-02-20SELL-12116.92017.320 17.280USD -2,091 17.73 Profit of 55 on sale
2025-02-19BUY24217.32017.610 17.581USD 4,255 17.74
2025-02-18BUY12117.71019.250 19.096USD 2,311 17.74
2024-12-30SELL-23216.58016.910 16.877USD -3,915 18.31 Profit of 332 on sale
2024-12-06SELL-11419.09020.920 20.737USD -2,364 18.26 Loss of -282 on sale
2024-12-04SELL-11417.22018.310 18.201USD -2,075 18.31 Profit of 13 on sale
2024-12-03SELL-23017.90018.610 18.539USD -4,264 18.33 Loss of -48 on sale
2024-11-21SELL-12017.07017.300 17.277USD -2,073 18.65 Profit of 165 on sale
2024-11-20SELL-12516.17017.940 17.763USD -2,220 18.79 Profit of 128 on sale
2024-11-19SELL-12518.06018.090 18.087USD -2,261 18.83 Profit of 93 on sale
2024-11-18SELL-46816.27017.370 17.260USD -8,078 18.99 Profit of 811 on sale
2024-11-12SELL-11619.58020.070 20.021USD -2,322 18.95 Loss of -124 on sale
2024-11-07SELL-11618.74019.280 19.226USD -2,230 18.92 Loss of -36 on sale
2024-11-05SELL-23218.35018.400 18.395USD -4,268 19.02 Profit of 146 on sale
2024-10-28SELL-11719.57020.130 20.074USD -2,349 19.72 Loss of -41 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ARCT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19263,050654445,27659.1%
2025-09-18243,055128528,08646.0%
2025-09-17153,5060239,67364.0%
2025-09-16168,941250384,53643.9%
2025-09-1581,7420158,51551.6%
2025-09-12147,7100262,85556.2%
2025-09-1199,5863,939173,74857.3%
2025-09-1082,21610142,60757.7%
2025-09-0996,67911151,44463.8%
2025-09-0883,37725159,52752.3%
2025-09-0587,7591183,08647.9%
2025-09-0484,27191145,29658.0%
2025-09-0372,0681141,17451.0%
2025-09-0239,080082,14747.6%
2025-08-2980,961257179,95945.0%
2025-08-2888,08998225,06839.1%
2025-08-2738,893086,06045.2%
2025-08-2628,8122094,45430.5%
2025-08-2548,8361,396130,33837.5%
2025-08-2263,14622161,24039.2%
2025-08-2171,2331,783200,63635.5%
2025-08-2088,9681205,86843.2%
2025-08-19124,2191,874282,77643.9%
2025-08-18349,598677543,67664.3%
2025-08-15182,9676365,20550.1%
2025-08-14296,71319,441723,75541.0%
2025-08-13320,8312,493788,74940.7%
2025-08-12344,7022,010749,29646.0%
2025-08-11147,0710479,08130.7%
2025-08-0888,4380154,47357.3%
2025-08-0767,88630120,28656.4%
2025-08-0689,15730150,30759.3%
2025-08-0565,36440123,32353.0%
2025-08-0454,4070108,26250.3%
2025-08-0179,124113125,15963.2%
2025-07-3174,466225148,21650.2%
2025-07-3075,71019,477219,17134.5%
2025-07-29201,6942,041281,19271.7%
2025-07-2842,509176109,53338.8%
2025-07-25111,4041,103158,92070.1%
2025-07-2434,55151493,84936.8%
2025-07-2385,6542,416153,96355.6%
2025-07-2244,8060104,40542.9%
2025-07-2146,543095,17648.9%
2025-07-1843,13910284,12851.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.